As the world emerges from the pandemic, markets are now contending with an energy crisis, a global shipping glut and the prospect of central banks starting to raise interest rates.

But so far this week, investors are shrugging it all off as the ASX posted another round of solid gains today.

The iron ore majors are failing upwards, plenty of experts reckon gold stocks are still a buy while the ASX 200 Information Technology sector — which recently has tended to lag when yields start to rise — has outperformed for the last two days.

All up, the ASX 200 rose by another 0.53% today, outpacing the small end of town as the microcap Emerging Companies index traded flat.

The only sector to give back some ground was the ASX 200 Energy index, which fell by 1% after a torrid month for oil and uranium stocks.


Stocks highlighted in yellow rose after making announcements during the trading day.

Scroll or swipe to reveal table. Click headings to sort.

Wordpress Table Plugin

Near the front of today’s winner’s list was one of three new IPOS on the ASX, all of which gained ground.

The best performer was Alvo Minerals (ASX:ALV), which has raised funds to explore its ‘Palma’ VMS project in Brazil, which has a resource of 4.6 million tonnes at 1.0% copper, 3.9% zinc, 0.4% lead and 20g/t gold. ALV shares rose more than 50% on debut.

Shares in uranium company A-Cap Resources (ASX:ACB) also ripped higher by more than 50% on no news.

Resources and energy stocks largely populated today’s winner’s list, while cancer screening device maker Truscreen (ASX:TRU) held its gains after flagging an expanded distribution pathway into the Chinese market through a domestic distributor for its TruScreen Made in China device.


Scroll or swipe to reveal table. Click headings to sort.

Wordpress Table Plugin


Opthamology biotech Opthea (ASX:OPT) opened patient enrollment in the Asia-Pacific region for its Phase 3 trial for its OPT-302 drug. The trial, following on from its successful Phase 2 trial in 2018-19, will test OPT-302 against wet-AMD.

James Spenceley, chairman of Swoop Telecommunications (ASX:SWP) and Airtasker (ASX:ART) as well as the founder of Vocus (ASX:VOC) is joining yet another board. He is becoming a non-executive director of NAB (ASX:NAB), effective on December 1.

Suvo Strategic Minerals (ASX:SUV) hired a new Chief Financial Offer in Bojan Bogunovic. He joins the company having served in senior financial roles with several other resources companies, most recently Kalium Lakes (ASX:KLL).

Accounting outfit CountPlus (ASX:CUP) finalised a deal to buy SMSF actuarial certificate supplier Accurium from Challenger (ASX:CGF). It will pay $9 million using a combination of cash and a bank debt facility.

Hubify (ASX:HFY) unveiled a deal to supply Optus Enterprise customers IT services. The deal is backdated to be effective on October 1 and will contribute $4 million in annualised recurring revenue.

Osprey Medical (ASX:OSP) released its quarterly report in which it unveiled record sales in Europe. It’s worldwide net sales were 1,773 which was 50% higher than the prior corresponding period.

Credit Intelligence (ASX:CL1) has launched its consumer debt management mobile app on the Apple and Google stores that will help Australian clients manage their debts without impacting their credit profiles through Bankruptcy and Part IX Debt Agreements.



Centrex Metals (ASX:CXM) – marketing services term sheet
Cannon Resources (ASX:CNR) – capital raising
Zelira Therapeutics (ASX:ZLD) – capital raising
Allegiance Coal (ASX:AHQ) – acquisition and capital raising
Prophecy International (ASX:PRO) – capital raising
Peak Minerals (ASX:PUA) – capital raising
Impedimed (ASX:IPD) – clinical trial results
AD1 Holdings (ASX:AD1) – capital raising


Lithium Australia (ASX:LIT) – collection and supply contract
Thomson Resources (ASX:TMZ) – capital raising
De Grey Mining (ASX:DEG) – capital raising
Ambertech (ASX:AMO) – capital raising
Top Shelf Holdings (ASX:TSI) – capital raising
ALE Property Group (ASX:LEP) – court judgement